SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Maulcoin

Maulcoin is surging in popularity as investors rally behind its community-driven, "no-rug" philosophy, with many holding strong in anticipation of further gains and potential airdrops. The community is actively coordinating to drive volume and increase social media visibility, framing the stock as an emerging contender against established meme coins.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Markets are under pressure as U.S.-Iran peace talks in Pakistan concluded without a deal, fueling uncertainty over the status of the Strait of Hormuz and energy supplies. While some community members are bracing for a volatile opening based on geopolitical risks, others remain skeptical, citing a pattern of tactical market manipulation and anticipation of further government commentary.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF is experiencing intense volatility as investors debate whether the sector's parabolic growth is reaching a exhaustion point or if the AI-driven capex cycle remains durable. While sentiment is divided between bulls betting on structural AI dominance and bears warning of a crowded bubble and macro-economic headwinds, the community is focused on whether critical technical support levels can hold as capital rotates into laggard sectors.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is currently caught in a tug-of-war as investors closely monitor high-stakes negotiations between the U.S. and Iran regarding the Strait of Hormuz, with market sentiment swinging between hopes for a de-escalation deal and concerns over continued geopolitical instability. The community remains deeply divided, with bulls pointing to strong institutional ETF inflows and accumulation as signs of a breakout, while bears argue that price action is merely a relief rally within a broader downtrend waiting for a catalyst to push assets lower.

Petróleo Brasileiro SA engages in oil and gas exploration, production, and distribution activities. It operates through the following segments: Exploration and Production; Refining, Transportation, and Marketing; and Gas and Low Carbon Energies. The Exploration and Production segment covers the activities of exploration, development, and production of crude oil, natural gas liquid, and natural gas, for the primary purpose of supplying its domestic refineries. The Refining, Transportation, and Marketing segment refers to refining, logistics, transport, and trading of crude oil and oil products activities as well as exports of ethanol. The Gas and Low Carbon Energies represents the activities of logistic and trading of natural gas and electricity, transportation and trading of liquefied natural gas, generation and electricity by means of thermoelectric power plants, as well as holding interests in transporters and distributors of natural gas. The company was founded on October 3, 1953 and is headquartered in Rio de Janeiro, Brazil.

Petroleo Brasileiro S.A. Petrobras - ADR

Petroleo Brasileiro

Petrobras is trending as investors debate its valuation relative to global majors amid ongoing geopolitical volatility in the Middle East, with many in the community focusing on the company's robust production growth, deep-value metrics, and reliable dividend payouts. While some traders are monitoring regional political risks and currency fluctuations, the broader sentiment remains bullish for those betting on a multi-year commodity cycle.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing significant downward pressure following its latest investor day, where the company outlined a long-term roadmap to profitability by the end of the decade despite continued cash burn and production delays. While some investors see potential in the newly unveiled midsize EV platform and robotaxi initiatives, the community remains heavily divided between those betting on a major short squeeze and those increasingly skeptical of the company's ability to survive without further dilution.

ASML Holding NV engages in the development, production, marketing, sales, upgrading and servicing of advanced semiconductor equipment systems. It includes lithography, metrology and inspection systems. The company was founded on April 1, 1984 and is headquartered in Veldhoven, the Netherlands.

ASML Holding NV - New York Shares

ASML Holding NV

ASML is trending as investors weigh its critical role in the global AI semiconductor supply chain against heightened geopolitical risks, particularly the potential for supply chain disruptions in the Strait of Hormuz. The community is actively debating the company's valuation versus its strategic 'bottleneck' status as a monopoly for advanced lithography equipment.

iShares Inc. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF (EWY) is currently a major focus for investors acting as a proxy for the global AI infrastructure buildout, driven by explosive demand for high-bandwidth memory (HBM) chips. The community is actively debating the stock's role in the semiconductor cycle, closely monitoring earnings from top holdings like Samsung and SK Hynix while weighing risks related to geopolitical tensions, energy supply, and potential trade shifts.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market sentiment for QQQ is currently dominated by intense speculation surrounding the high-stakes ceasefire negotiations between the U.S. and Iran in Pakistan, with traders actively debating whether the rally is a durable reversal or a fragile bear market bounce. Community discussion is focused on the geopolitical risks of the Strait of Hormuz, with many participants expressing skepticism about a lasting deal and monitoring potential volatility as they weigh the impact of shifting military maneuvers and energy costs on future price action.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending as the community highlights its role as a critical supply chain partner for underwater drone fleets amid heightened geopolitical tensions in the Strait of Hormuz. Investors are actively discussing the company's defensive tailwinds and vertical integration strategy, viewing recent pullbacks as opportunities to build long-term positions in a key player within the emerging subsea infrastructure market.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why GSK (GSK) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

<ul class="summary-bullets"><li>FDA approved leucovorin in the treatment of cerebral folate transport deficiency last month but not in autism.</li><li>Leucovorin garnered attention in the latter half of 2025 after Donald Trump and his administration promoted it as an "exciting" and “promising” therapeutic for autism.</li><li>According to research published in The Lancet, outpatient leucovorin prescriptions for children aged 5–17 years increased by 71% following the press briefing in September.</li></ul>UK drugmaker GSK Plc (GSK) has withdrawn its application for the drug leucovorin calcium touted by President Trump as a potential treatment for autism.GSK asked the U.S. Food and Drug Administration to pull its application for leucovorin calcium because it no longer markets the medicine, a filing on the FDA website shows.The news was first reported by The Wall Street Journal. &nbsp;<h2 class="st-heading-2">Leucovorin Approval And Claims</h2>According <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/health/pharma/gsk-nixes-application-for-drug-touted-by-trump-for-autism-4d5bdead">to </a>WSJ, GSK said in September that it would submit an application for the drug in the treatment of cerebral folate transport deficiency following a request from the FDA. The agency approved the drug for the condition last month, but not for autism. The company, however, hasn’t sold the drug since 1999, the report noted. &nbsp;A GSK spokesperson reportedly told the newspaper that the company never intended to sell the drug again. Meanwhile, a spokesperson for the U.S. Department of Health and Human Services told the paper that GSK’s decision has no bearing on generic versions of the drug for patients with cerebral folate deficiency.Leucovorin garnered attention in the latter half of 2025 after Donald Trump and his administration promoted it as an "exciting" and “promising” therapeutic for autism. According to <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00243-6/fulltext">research</a> published in The Lancet, outpatient leucovorin prescriptions for children aged 5–17 years increased by 71% following the press briefing in September where Trump made his claims with Robert F Kennedy Jr.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around GSK stock stayed within the ‘bearish’ territory, while message volume remained at ‘low’ levels.<a href="https://stocktwits.com/symbol/GSK">GSK stock</a> has gained 69% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/tsla-stock-heads-for-8th-straight-week-of-price-decline/cZJWlLZRIsZ">TSLA Stock Heads For 8th Straight Week Of Price Decline — What’s Driving The Selloff?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of GSK plc is displayed on a smartphone screen, on April 26, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

GSK Reportedly Pulls Application For Drug Touted By Trump As Potential Treatment For Autism

According to a report from the Wall Street Journal on Thursday, GSK asked the FDA to pull its application for leucovorin calcium because it no longer markets the medicine.

Equity

GSK plc (LON:GSK) Receives Consensus Recommendation of "Hold" from Analysts

Shares of GSK plc (LON:GSK - Get Free Report) have been given a consensus recommendation of "Hold" by the seven brokerages that are presently covering the firm, Marketbeat.com reports. One research...

GSK (GSK) is a Top-Ranked Value Stock: Should You Buy?

From Lungs To Nasal Polyps: Sanofi Finds Success With 2-in-1 Inflammation Blocker

Sanofi reports positive Phase 2 data for lunsekimig in asthma and nasal polyps, while atopic dermatitis study misses main goal.read more...

GSK (LON:GSK) Given "Buy" Rating at Jefferies Financial Group

Jefferies Financial Group restated a "buy" rating and issued a GBX 2,450 price objective on shares of GSK in a research report on Thursday...

Trump Administration Prepares 100% Tariffs On Drugmakers Without Pricing Deals: Report

According to a Bloomberg report, Trump may impose 100% tariffs on drugmakers without pricing deals, as part of a broader push to lower drug costs.read more...

GSK PLC Sponsored ADR (NYSE:GSK) Receives Average Recommendation of "Reduce" from Analysts

Shares of GSK PLC Sponsored ADR (NYSE:GSK - Get Free Report) have received an average recommendation of "Reduce" from the eleven ratings firms that are currently covering the firm, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell recommendation, seven ha...

Bristol Myers Squibb adding 3 medications on TrumpRx

EXCLUSIVE: Bristol Myers Squibb is launching three medications on TrumpRx.gov on Monday, FOX Business has learned.The three prescription drugs will each be offered at deep discounts that range from 40% to 90% off the retail price.The Princeton, New Jersey-based company's drug Sotyktu retails for...

GSK Sets Up Late-Stage Readouts: Chronic Cough Phase 3 Data Near, Hep B Filing on Track

GSK (NYSE:GSK) respiratory, immunology and inflammation R&D head Kaivan Khavandi said the company is positioning several late-stage programs around clear unmet need and what he described as better "target trait pairing," highlighting upcoming chronic cough data, planned hepatitis B regulatory st...

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	$1.16	--	--	N/A
Q4 '25	$0.64	$0.70	8.50%	BEAT
Q3 '25	$1.26	$1.46	15.86%	BEAT
Q2 '25	$1.17	$1.24	5.58%	BEAT
Q1 '25	$1.07	$1.20	12.42%	BEAT

GSK
Glaxosmithkline plc - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest GSK News

GSKGlaxosmithkline plc - ADR